Kiora Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $-15,951 | $0 | $20 | $16,000 |
Gross Profit | -15,985 | 2 | 15,983 | |
EBITDA | -2,399 | -2,696 | -2,418 | 13,469 |
EBIT | -2,405 | -2,698 | -2,436 | 13,453 |
Net Income | -4,223 | -3,413 | -2,221 | 13,453 |
Net Change In Cash | -15,951 | 0 | 20 | 16,000 |
Free Cash Flow | -2,207 | 920 | -3,784 | 13,624 |
Cash | 3,792 | 5,637 | 6,575 | 31,276 |
Basic Shares | 4,125 | 4,214 | 4,170 | 35,025 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $16,020 | $0 | $0 | $12 |
Gross Profit | 16,020 | -4,027 | -134 | -227 |
EBITDA | 5,700 | -12,350 | -13,553 | -13,729 |
EBIT | 5,681 | -12,412 | -13,688 | -13,956 |
Net Income | 3,594 | -12,513 | -13,583 | -16,394 |
Net Change In Cash | 16,020 | 0 | 0 | 12 |
Free Cash Flow | 8,552 | -9,556 | -10,428 | -10,951 |
Cash | 3,792 | 2,454 | 5,964 | 7,854 |
Basic Shares | 4,125 | 538 | 732 | 241 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.20 |
2024-09-30 | -$0.81 |
2024-06-30 | -$0.53 |
2024-03-31 | $0.38 |
